-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Methotrimeprazine maleate is a pharmaceutical drug used to treat various central nervous system disorders.
It belongs to the class of drugs called piperazines and has an antihistamine, antipsychotic, and sedative effect.
The synthetic routes of methotrimeprazine maleate have been extensively studied and developed over the years.
This article will discuss the synthetic routes of methotrimeprazine maleate, including the traditional route and the newer, more efficient routes.
Traditional Synthetic Route
The traditional synthetic route of methotrimeprazine maleate involves several steps, including the synthesis of the piperazine ring and the introduction of the maleic acid group.
The following is a description of the traditional synthetic route:
Step 1: N-Methyl-D-Aspartate (NMDA) Synthesis
The synthesis of N-methyl-D-aspartate (NMDA), a key intermediate for methotrimeprazine maleate, involves the reaction of D-aspartic acid with methylamine.
The reaction is typically carried out in the presence of a strong acid catalyst, such as hydrochloric acid, and results in the formation of NMDA.
Step 2: N-Methyl-D-Aspartate Condensation
The next step in the synthesis of methotrimeprazine maleate is the condensation of NMDA with another intermediate, 2-amino-6-chloropyrimidine.
This reaction involves the use of a condensation agent, such as dicyclohexylcarbodiimide (DCC), to form a polymeric intermediate.
Step 3: Piperazine Ring Synthesis
The next step in the synthesis of methotrimeprazine maleate is the synthesis of the piperazine ring.
This is typically achieved through the reaction of the polymeric intermediate from step 2 with a reactive piperazine derivative, such as N-hydroxyphenylpiperazine.
This reaction involves the use of a coupling agent, such as dicyclohexylcarbodiimide (DCC), to form the final piperazine ring.
Step 4: Maleic Acid Introduction
The final step in the synthesis of methotrimeprazine maleate involves the introduction of the maleic acid group.
This is typically achieved through the reaction of the piperazine derivative from step 3 with maleic anhydride.
The reaction is typically carried out in the presence of a strong acid catalyst, such as sulfuric acid, and results in the formation of methotrimeprazine maleate.
Newer Synthetic Routes
In recent years, several newer and more efficient synthetic routes to methotrimeprazine maleate have been developed.
These routes often involve the use of novel reagents and catalysts, and can be more efficient and cost-effective than the traditional route.
One such route involves the use of a reactive amide intermediate, rather than the traditional NMDA intermediate.
This route was reported in a publication by Takeda Pharmaceuticals in 2012 and involves the following steps:
Step 1: N-Methyl-D-Aspartate (NMDA) Synthesis
The synthesis of NMDA involves the reaction of D-aspartic acid with methylamine, as in the traditional route.
Step 2: Amide Intermediate Synthesis
The next step in the synthesis of methotrimeprazine maleate using this route is the synthesis of a reactive amide intermediate.
This is typically achieved through the reaction of NMDA with a reactive amide, such as hydroxyproline.
Step 3: Piperazine Ring Synthesis
The next step in the synthesis of methotrimeprazine maleate using this route is the synthesis of the piperazine ring.
This is typically achieved through the reaction of the amide intermediate from step 2 with a reactive piperazine derivative, such as N-hydroxyphenylpiperazine.
Step 4: Maleic Acid Introduction
The